結腸直腸がん分子診断の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR1454)
◆英語タイトル:Global Colorectal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR1454
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、結腸直腸がん分子診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(PCR診断、質量分析診断、その他)、用途別市場規模(病院、外来手術センター、診断研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・結腸直腸がん分子診断の市場動向
・企業の競争状況、市場シェア
・結腸直腸がん分子診断の種類別市場規模(PCR診断、質量分析診断、その他)
・結腸直腸がん分子診断の用途別市場規模(病院、外来手術センター、診断研究所)
・結腸直腸がん分子診断の北米市場規模2016-2027(アメリカ、カナダ)
・結腸直腸がん分子診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・結腸直腸がん分子診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結腸直腸がん分子診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・結腸直腸がん分子診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Agilent、Hologic、Qiagen、Roche、Bayer、Abbott、Grifols、Danaher、Siemens、BD、Biomérieux、Sysmex)
・結論
【レポートの概要】

Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine. Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.

Market Analysis and Insights: Global Colorectal Cancer Molecular Diagnostics Market
The global Colorectal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Molecular Diagnostics market.

Global Colorectal Cancer Molecular Diagnostics Scope and Market Size
Colorectal Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR Diagnostics
Mass spectrometry Diagnostics
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent
Hologic
Qiagen
Roche
Bayer
Abbott
Grifols
Danaher
Siemens
Roche

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR Diagnostics
1.2.3 Mass spectrometry Diagnostics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Colorectal Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Colorectal Cancer Molecular Diagnostics Market Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2020
3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Agilent Recent Development
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Hologic Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Hologic Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Roche Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Bayer Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Grifols Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Grifols Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Danaher Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Danaher Recent Development
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Siemens Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Siemens Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 BD Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 BD Recent Development
11.11 Biomérieux
11.11.1 Biomérieux Company Details
11.11.2 Biomérieux Business Overview
11.11.3 Biomérieux Colorectal Cancer Molecular Diagnostics Introduction
11.11.4 Biomérieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Biomérieux Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Colorectal Cancer Molecular Diagnostics Introduction
11.12.4 Sysmex Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.12.5 Sysmex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 結腸直腸がん分子診断の世界市場規模・現状・予測2021年-2027年(Global Colorectal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。